David Fuhrer

Management Team

Meet the People Behind Neopharm

Group Chairman

David Fuhrer has led Neopharm Group since the 1980s. Under his leadership, Neopharm became one of the largest pharmaceutical and consumer product companies in Israel, through collaborations, mergers and acquisitions in both existing and new fields. Fuhrer is one of the leading and most influential figures in Israel's industry and commerce sector, particularily in the health products market. He is known for his unique philanthropic initiatives, which support the advancement of research in medicine and the life sciences.

Phone: +972-3-9373705
d.fuhrer@neopharmgroup.com

Contact Us

David Fuhrer joined Neopharm in 1980 as the manager of the veterinary products and chemicals division. Under his leadership, the company developed and flourished, becoming one of Israel's healthcare leaders. In 1986, Fuhrer was appointed CEO of the company.

Following the acquisitions of "Eldan Electronic Instruments" and "Promedico", Fuhrer was appointed Chairman of Neopharm Group.

Fuhrer holds a law degree from Tel Aviv University and is a member of the Israel Bar Association.

Fuhrer is deeply involved in Israel's business community. Among other roles, he served as Chairman of the Friends Association of Bar-Ilan University, and in 2009 received an honorary doctorate from Bar-Ilan University for his contribution to Israel's pharmaceutical industry. In 2011, he received an honorary fellowship from the Interdisciplinary Center Herzliya for his contribution to industry and the community, and in 2018 he received the Superbrands Marketing Leader Award. Fuhrer is a member of the Boards of Trustees of Bar-Ilan University and Tel Aviv University and of the Friends Association of the Interdisciplinary Center.